United States Biotechnology & Medical Research

Alector Inc (ALEC)

Track

Track

Alector Inc. experienced significant insider selling over the past ninety days, totaling approximately $285,189 in net value. Key executives, including the CEO and CFO, offloaded shares following the August earnings report. These transactions reflect a consistent pattern of divestment by leadership, despite the stock price showing a modest 7.3% gain during this period.
Ticker: ALEC Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Alector Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Wong-Sarad Grace Principal Accounting Officer Officer
Transaction date
Planned sale
Price
219.90
Quantity 29,027 -3.3%
Value US$4,695,236
2.2
GRACE WONG-SARAD Officer Officer
Transaction date
Proposed sale
Price
466.05
Quantity 6,976
Value US$4,726,944
2.2
Wong-Sarad Grace Principal Accounting Officer Officer
Transaction date
Sale
Price
133.77
Quantity 38,031 +31.2%
Value US$2,299,616
3.1
Rosenthal Arnon Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.66
Quantity 1,000 -3.1%
Value US$100,000
2.0
Berkley Neil Lindsay CFO & Chief Business Officer Officer
Transaction date
Sale
Price
2.66
Quantity 1,000 -7.7%
Value US$100,000
2.2
Wong-Sarad Grace Principal Accounting Officer Officer
Transaction date
Planned sale
Price
2.75
Quantity 1,000 -0.6%
Value US$100,000
2.2
GRACE WONG-SARAD Officer Officer
Transaction date
Proposed sale
Price
2.75
Quantity 656
Value US$1,804
2.2
Grace Wong-Sarad Officer Officer
Transaction date
Proposed sale
Price
2.40
Quantity 5,662
Value US$13,589
3.1
Arnon Rosenthal Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.40
Quantity 79,702
Value US$191,285
2.0
Neil L. Berkley Officer Officer
Transaction date
Proposed sale
Price
2.40
Quantity 32,103
Value US$77,047
2.2
Wong-Sarad Grace Principal Accounting Officer Officer
Transaction date
Planned sale
Price
1.88
Quantity 3,475 -3.5%
Value US$6,543
2.2
GRACE WONG-SARAD Officer Officer
Transaction date
Proposed sale
Price
1.88
Quantity 3,475
Value US$6,543
2.2
Wong-Sarad Grace Principal Accounting Officer Officer
Transaction date
Sale
Price
1.97
Quantity 5,709 -5.5%
Value US$11,271
3.1
Rosenthal Arnon Chief Executive Officer Executive Director
Transaction date
Sale
Price
1.97
Quantity 87,216 -3.6%
Value US$172,191
2.0
Berkley Neil Lindsay CFO & Chief Business Officer Officer
Transaction date
Sale
Price
1.97
Quantity 19,360 -4.8%
Value US$38,221
2.2
Grace Wong-Sarad Officer Officer
Transaction date
Proposed sale
Price
2.07
Quantity 5,239
Value US$10,845
2.0
Neil L. Berkley Officer Officer
Transaction date
Proposed sale
Price
2.07
Quantity 18,213
Value US$37,701
3.1
Arnon Rosenthal Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.07
Quantity 67,572
Value US$139,874
2.2
Wong-Sarad Grace Principal Accounting Officer Officer
Transaction date
Planned sale
Price
2.65
Quantity 1,820 -1.7%
Value US$4,823
2.2
GRACE WONG-SARAD Officer Officer
Transaction date
Proposed sale
Price
2.65
Quantity 1,820
Value US$4,823
2.2
Wong-Sarad Grace Principal Accounting Officer Officer
Transaction date
Planned sale
Price
2.65
Quantity 1,000 -0.9%
Value US$2,650
2.2
GRACE WONG-SARAD Officer Officer
Transaction date
Proposed sale
Price
2.65
Quantity 1,000
Value US$2,650
2.2
Wong-Sarad Grace Principal Accounting Officer Officer
Transaction date
Planned sale
Price
2.08
Quantity 3,367 -3.0%
Value US$7,012
2.2
GRACE WONG-SARAD Officer Officer
Transaction date
Proposed sale
Price
2.08
Quantity 3,367
Value US$7,012
2.2
Wong-Sarad Grace Principal Accounting Officer Officer
Transaction date
Sale
Price
2.12
Quantity 8,071 -6.8%
Value US$17,138
3.1
Rosenthal Arnon Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.12
Quantity 81,864 -3.4%
Value US$173,822
2.0
Berkley Neil Lindsay CFO & Chief Business Officer Officer
Transaction date
Sale
Price
2.12
Quantity 29,649 -7.9%
Value US$62,954
2.0
Neil L. Berkley Officer Officer
Transaction date
Proposed sale
Price
2.43
Quantity 23,161
Value US$56,281
3.1
Arnon Rosenthal Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.43
Quantity 67,571
Value US$164,198
2.2
Grace Wong-Sarad Officer Officer
Transaction date
Proposed sale
Price
2.43
Quantity 6,297
Value US$15,302
2.2
Wong-Sarad Grace Principal Accounting Officer Officer
Transaction date
Planned sale
Price
2.50
Quantity 4,079 -3.3%
Value US$10,198
2.2
GRACE WONG-SARAD Officer Officer
Transaction date
Proposed sale
Price
2.50
Quantity 4,079
Value US$10,198
2.2
Wong-Sarad Grace Principal Accounting Officer Officer
Transaction date
Planned sale
Price
1.21
Quantity 4,753 -3.7%
Value US$5,751
2.2
GRACE WONG-SARAD Officer Officer
Transaction date
Proposed sale
Price
1.21
Quantity 4,753
Value US$5,751
3.6
Kenkare-Mitra Sara President and Head of R&D Officer
Transaction date
Sale
Price
1.12
Quantity 41,687 -7.7%
Value US$46,673
2.2
Wong-Sarad Grace Principal Accounting Officer Officer
Transaction date
Sale
Price
1.12
Quantity 8,056 -5.9%
Value US$9,019
3.1
Rosenthal Arnon Chief Executive Officer Executive Director
Transaction date
Sale
Price
1.12
Quantity 104,347 -4.1%
Value US$116,827
2.0
Berkley Neil Lindsay Chief Bus Ofcr & Interim CFO Officer
Transaction date
Sale
Price
1.12
Quantity 37,261 -9.1%
Value US$41,717
3.1
Arnon Rosenthal Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.23
Quantity 92,427
Value US$113,685
2.0
Neil L. Berkley Officer Officer
Transaction date
Proposed sale
Price
1.23
Quantity 32,992
Value US$40,580
2.2
Grace Wong-Sarad Officer Officer
Transaction date
Proposed sale
Price
1.23
Quantity 7,085
Value US$8,715
3.6
Sara Kenkare-Mitra Officer Officer
Transaction date
Proposed sale
Price
1.23
Quantity 36,914
Value US$45,404
2.0
Berkley Neil Lindsay Principal Financial Officer Officer
Transaction date
Sale
Price
2.50
Quantity 15,842 -4.4%
Value US$39,554
2.2
Wong-Sarad Grace Principal Accounting Officer Officer
Transaction date
Sale
Price
2.50
Quantity 5,910 -5.4%
Value US$14,756
3.6
Kenkare-Mitra Sara President and Head of R&D Officer
Transaction date
Sale
Price
2.50
Quantity 23,638 -4.2%
Value US$59,019
3.1
Rosenthal Arnon Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.50
Quantity 51,562 -2.1%
Value US$128,740
2.0
Neil L. Berkley Officer Officer
Transaction date
Proposed sale
Price
2.35
Quantity 15,426
Value US$36,251
2.2
Grace Wong-Sarad Officer Officer
Transaction date
Proposed sale
Price
2.35
Quantity 5,717
Value US$13,435
3.6
Sara Kenkare-Mitra Officer Officer
Transaction date
Proposed sale
Price
2.35
Quantity 23,019
Value US$54,095
3.1
Arnon Rosenthal Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.35
Quantity 50,242
Value US$118,069
Hammond Paula Non-Executive Director
Transaction date
Planned sale
Price
2.36
Quantity 14,000 -15.7%
Value US$32,998
PAULA HAMMOND Director Non-Executive Director
Transaction date
Proposed sale
Price
2.36
Quantity 14,000
Value US$32,997
3.9
MARC GRASSO Officer Officer
Transaction date
Proposed sale
Price
2.00
Quantity 76,446
Value US$152,892
0.5
Yaffe Kristine Non-Executive Director
Transaction date
Sale
Price
1.44
Quantity 1,000 -1.0%
Value US$1,440
3.6
Kenkare-Mitra Sara President and Head of R&D Officer
Transaction date
Sale
Price
1.34
Quantity 23,890 -4.5%
Value US$31,974
3.9
GRASSO MARC Chief Financial Officer Officer
Transaction date
Sale
Price
1.34
Quantity 16,488 -5.3%
Value US$22,068
3.1
Rosenthal Arnon Chief Executive Officer Executive Director
Transaction date
Sale
Price
1.34
Quantity 52,087 -2.1%
Value US$69,713
3.6
Sara Kenkare-Mitra Officer Officer
Transaction date
Proposed sale
Price
1.33
Quantity 23,020
Value US$30,617
3.1
Arnon Rosenthal Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.33
Quantity 50,242
Value US$66,822
3.9
Marc Grasso Officer Officer
Transaction date
Proposed sale
Price
1.33
Quantity 15,873
Value US$21,111
3.9
GRASSO MARC Chief Financial Officer Officer
Transaction date
Sale
Price
1.47
Quantity 18,091 -5.5%
Value US$26,547
4.1
Romano Gary Chief Medical Officer Officer
Transaction date
Sale
Price
1.47
Quantity 16,306 -4.7%
Value US$23,927
3.1
Rosenthal Arnon Chief Executive Officer Executive Director
Transaction date
Sale
Price
1.47
Quantity 40,330 -1.6%
Value US$59,176
3.6
Kenkare-Mitra Sara President and Head of R&D Officer
Transaction date
Sale
Price
1.47
Quantity 29,073 -5.1%
Value US$42,662
4.1
Gary Romano Officer Officer
Transaction date
Proposed sale
Price
1.64
Quantity 14,306
Value US$23,462
3.1
Arnon Rosenthal Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.64
Quantity 50,242
Value US$82,397
3.9
Marc Grasso Officer Officer
Transaction date
Proposed sale
Price
1.64
Quantity 15,873
Value US$26,032
3.6
Sara Kenkare-Mitra Officer Officer
Transaction date
Proposed sale
Price
1.64
Quantity 25,516
Value US$41,846
3.9
GRASSO MARC Chief Financial Officer Officer
Transaction date
Sale
Price
2.52
Quantity 16,489 -4.7%
Value US$41,542
4.1
Romano Gary Chief Medical Officer Officer
Transaction date
Sale
Price
2.52
Quantity 14,892 -4.1%
Value US$37,519
3.6
Kenkare-Mitra Sara President and Head of R&D Officer
Transaction date
Sale
Price
2.52
Quantity 26,500 -4.5%
Value US$66,764
3.1
Rosenthal Arnon Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.52
Quantity 52,172 -2.0%
Value US$131,442
4.1
Gary Romano Officer Officer
Transaction date
Proposed sale
Price
2.59
Quantity 14,306
Value US$37,053
3.6
Sara Kenkare-Mitra Officer Officer
Transaction date
Proposed sale
Price
2.59
Quantity 25,465
Value US$65,954
3.9
Marc Grasso Officer Officer
Transaction date
Proposed sale
Price
2.59
Quantity 15,842
Value US$41,031
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-04 2026-09-04 PlS Planned sale
2.2
Wong-Sarad Grace

Principal Accounting Officer

Officer
29,027 -3.3%
219.90
US$4,695,236 		29,027 -3.3% 219.90 US$4,695,236
2026-09-04 2026-09-04 PrS Proposed sale
2.2
GRACE WONG-SARAD

Officer

Officer
6,976
466.05
US$4,726,944 		6,976 466.05 US$4,726,944
2026-09-04 2026-09-03 S Sale
2.2
Wong-Sarad Grace

Principal Accounting Officer

Officer
38,031 +31.2%
133.77
US$2,299,616 		38,031 +31.2% 133.77 US$2,299,616
2026-09-04 2026-09-03 S Sale
3.1
Rosenthal Arnon

Chief Executive Officer

Executive Director
1,000 -3.1%
2.66
US$100,000 		1,000 -3.1% 2.66 US$100,000
2026-09-04 2026-09-03 S Sale
2.0
Berkley Neil Lindsay

CFO & Chief Business Officer

Officer
1,000 -7.7%
2.66
US$100,000 		1,000 -7.7% 2.66 US$100,000
2026-09-04 2026-09-02 PlS Planned sale
2.2
Wong-Sarad Grace

Principal Accounting Officer

Officer
1,000 -0.6%
2.75
US$100,000 		1,000 -0.6% 2.75 US$100,000
2026-09-02 2026-09-02 PrS Proposed sale
2.2
GRACE WONG-SARAD

Officer

Officer
656
2.75
US$1,804 		656 2.75 US$1,804
2026-09-01 2026-09-02 PrS Proposed sale
2.2
Grace Wong-Sarad

Officer

Officer
5,662
2.40
US$13,589 		5,662 2.40 US$13,589
2026-09-01 2026-09-02 PrS Proposed sale
3.1
Arnon Rosenthal

Officer; Director

Executive Director
79,702
2.40
US$191,285 		79,702 2.40 US$191,285
2026-09-01 2026-09-02 PrS Proposed sale
2.0
Neil L. Berkley

Officer

Officer
32,103
2.40
US$77,047 		32,103 2.40 US$77,047
2026-06-03 2026-06-03 PlS Planned sale
2.2
Wong-Sarad Grace

Principal Accounting Officer

Officer
3,475 -3.5%
1.88
US$6,543 		3,475 -3.5% 1.88 US$6,543
2026-06-03 2026-06-03 PrS Proposed sale
2.2
GRACE WONG-SARAD

Officer

Officer
3,475
1.88
US$6,543 		3,475 1.88 US$6,543
2026-06-03 2026-06-02 S Sale
2.2
Wong-Sarad Grace

Principal Accounting Officer

Officer
5,709 -5.5%
1.97
US$11,271 		5,709 -5.5% 1.97 US$11,271
2026-06-03 2026-06-02 S Sale
3.1
Rosenthal Arnon

Chief Executive Officer

Executive Director
87,216 -3.6%
1.97
US$172,191 		87,216 -3.6% 1.97 US$172,191
2026-06-03 2026-06-02 S Sale
2.0
Berkley Neil Lindsay

CFO & Chief Business Officer

Officer
19,360 -4.8%
1.97
US$38,221 		19,360 -4.8% 1.97 US$38,221
2026-06-01 2026-06-02 PrS Proposed sale
2.2
Grace Wong-Sarad

Officer

Officer
5,239
2.07
US$10,845 		5,239 2.07 US$10,845
2026-06-01 2026-06-02 PrS Proposed sale
2.0
Neil L. Berkley

Officer

Officer
18,213
2.07
US$37,701 		18,213 2.07 US$37,701
2026-06-01 2026-06-02 PrS Proposed sale
3.1
Arnon Rosenthal

Officer; Director

Executive Director
67,572
2.07
US$139,874 		67,572 2.07 US$139,874
2026-04-17 2026-04-16 PlS Planned sale
2.2
Wong-Sarad Grace

Principal Accounting Officer

Officer
1,820 -1.7%
2.65
US$4,823 		1,820 -1.7% 2.65 US$4,823
2026-04-16 2026-04-16 PrS Proposed sale
2.2
GRACE WONG-SARAD

Officer

Officer
1,820
2.65
US$4,823 		1,820 2.65 US$4,823
2026-03-12 2026-03-10 PlS Planned sale
2.2
Wong-Sarad Grace

Principal Accounting Officer

Officer
1,000 -0.9%
2.65
US$2,650 		1,000 -0.9% 2.65 US$2,650
2026-03-10 2026-03-10 PrS Proposed sale
2.2
GRACE WONG-SARAD

Officer

Officer
1,000
2.65
US$2,650 		1,000 2.65 US$2,650
2026-03-03 2026-03-03 PlS Planned sale
2.2
Wong-Sarad Grace

Principal Accounting Officer

Officer
3,367 -3.0%
2.08
US$7,012 		3,367 -3.0% 2.08 US$7,012
2026-03-03 2026-03-03 PrS Proposed sale
2.2
GRACE WONG-SARAD

Officer

Officer
3,367
2.08
US$7,012 		3,367 2.08 US$7,012
2026-03-03 2026-03-02 S Sale
2.2
Wong-Sarad Grace

Principal Accounting Officer

Officer
8,071 -6.8%
2.12
US$17,138 		8,071 -6.8% 2.12 US$17,138
2026-03-03 2026-03-02 S Sale
3.1
Rosenthal Arnon

Chief Executive Officer

Executive Director
81,864 -3.4%
2.12
US$173,822 		81,864 -3.4% 2.12 US$173,822
2026-03-03 2026-03-02 S Sale
2.0
Berkley Neil Lindsay

CFO & Chief Business Officer

Officer
29,649 -7.9%
2.12
US$62,954 		29,649 -7.9% 2.12 US$62,954
2026-02-27 2026-03-02 PrS Proposed sale
2.0
Neil L. Berkley

Officer

Officer
23,161
2.43
US$56,281 		23,161 2.43 US$56,281
2026-02-27 2026-03-02 PrS Proposed sale
3.1
Arnon Rosenthal

Officer; Director

Executive Director
67,571
2.43
US$164,198 		67,571 2.43 US$164,198
2026-02-27 2026-03-02 PrS Proposed sale
2.2
Grace Wong-Sarad

Officer

Officer
6,297
2.43
US$15,302 		6,297 2.43 US$15,302
2026-02-26 2026-02-26 PlS Planned sale
2.2
Wong-Sarad Grace

Principal Accounting Officer

Officer
4,079 -3.3%
2.50
US$10,198 		4,079 -3.3% 2.50 US$10,198
2026-02-26 2026-02-26 PrS Proposed sale
2.2
GRACE WONG-SARAD

Officer

Officer
4,079
2.50
US$10,198 		4,079 2.50 US$10,198
2025-12-08 2025-12-05 PlS Planned sale
2.2
Wong-Sarad Grace

Principal Accounting Officer

Officer
4,753 -3.7%
1.21
US$5,751 		4,753 -3.7% 1.21 US$5,751
2025-12-05 2025-12-05 PrS Proposed sale
2.2
GRACE WONG-SARAD

Officer

Officer
4,753
1.21
US$5,751 		4,753 1.21 US$5,751
2025-12-03 2025-12-03 S Sale
3.6
Kenkare-Mitra Sara

President and Head of R&D

Officer
41,687 -7.7%
1.12
US$46,673 		41,687 -7.7% 1.12 US$46,673
2025-12-03 2025-12-03 S Sale
2.2
Wong-Sarad Grace

Principal Accounting Officer

Officer
8,056 -5.9%
1.12
US$9,019 		8,056 -5.9% 1.12 US$9,019
2025-12-03 2025-12-03 S Sale
3.1
Rosenthal Arnon

Chief Executive Officer

Executive Director
104,347 -4.1%
1.12
US$116,827 		104,347 -4.1% 1.12 US$116,827
2025-12-03 2025-12-03 S Sale
2.0
Berkley Neil Lindsay

Chief Bus Ofcr & Interim CFO

Officer
37,261 -9.1%
1.12
US$41,717 		37,261 -9.1% 1.12 US$41,717
2025-12-01 2025-12-01 PrS Proposed sale
3.1
Arnon Rosenthal

Officer; Director

Executive Director
92,427
1.23
US$113,685 		92,427 1.23 US$113,685
2025-12-01 2025-12-01 PrS Proposed sale
2.0
Neil L. Berkley

Officer

Officer
32,992
1.23
US$40,580 		32,992 1.23 US$40,580
2025-12-01 2025-12-01 PrS Proposed sale
2.2
Grace Wong-Sarad

Officer

Officer
7,085
1.23
US$8,715 		7,085 1.23 US$8,715
2025-12-01 2025-12-01 PrS Proposed sale
3.6
Sara Kenkare-Mitra

Officer

Officer
36,914
1.23
US$45,404 		36,914 1.23 US$45,404
2025-09-04 2025-09-02 S Sale
2.0
Berkley Neil Lindsay

Principal Financial Officer

Officer
15,842 -4.4%
2.50
US$39,554 		15,842 -4.4% 2.50 US$39,554
2025-09-04 2025-09-02 S Sale
2.2
Wong-Sarad Grace

Principal Accounting Officer

Officer
5,910 -5.4%
2.50
US$14,756 		5,910 -5.4% 2.50 US$14,756
2025-09-04 2025-09-02 S Sale
3.6
Kenkare-Mitra Sara

President and Head of R&D

Officer
23,638 -4.2%
2.50
US$59,019 		23,638 -4.2% 2.50 US$59,019
2025-09-04 2025-09-02 S Sale
3.1
Rosenthal Arnon

Chief Executive Officer

Executive Director
51,562 -2.1%
2.50
US$128,740 		51,562 -2.1% 2.50 US$128,740
2025-08-29 2025-09-02 PrS Proposed sale
2.0
Neil L. Berkley

Officer

Officer
15,426
2.35
US$36,251 		15,426 2.35 US$36,251
2025-08-29 2025-09-02 PrS Proposed sale
2.2
Grace Wong-Sarad

Officer

Officer
5,717
2.35
US$13,435 		5,717 2.35 US$13,435
2025-08-29 2025-09-02 PrS Proposed sale
3.6
Sara Kenkare-Mitra

Officer

Officer
23,019
2.35
US$54,095 		23,019 2.35 US$54,095
2025-08-29 2025-09-02 PrS Proposed sale
3.1
Arnon Rosenthal

Officer; Director

Executive Director
50,242
2.35
US$118,069 		50,242 2.35 US$118,069
2025-08-27 2025-08-26 PlS Planned sale
Hammond Paula
Non-Executive Director
14,000 -15.7%
2.36
US$32,998 		14,000 -15.7% 2.36 US$32,998
2025-08-26 2025-08-26 PrS Proposed sale
PAULA HAMMOND

Director

Non-Executive Director
14,000
2.36
US$32,997 		14,000 2.36 US$32,997
2025-08-08 2025-08-08 PrS Proposed sale
3.9
MARC GRASSO

Officer

Officer
76,446
2.00
US$152,892 		76,446 2.00 US$152,892
2025-06-23 2025-06-20 S Sale
0.5
Yaffe Kristine
Non-Executive Director
1,000 -1.0%
1.44
US$1,440 		1,000 -1.0% 1.44 US$1,440
2025-06-04 2025-06-02 S Sale
3.6
Kenkare-Mitra Sara

President and Head of R&D

Officer
23,890 -4.5%
1.34
US$31,974 		23,890 -4.5% 1.34 US$31,974
2025-06-04 2025-06-02 S Sale
3.9
GRASSO MARC

Chief Financial Officer

Officer
16,488 -5.3%
1.34
US$22,068 		16,488 -5.3% 1.34 US$22,068
2025-06-04 2025-06-02 S Sale
3.1
Rosenthal Arnon

Chief Executive Officer

Executive Director
52,087 -2.1%
1.34
US$69,713 		52,087 -2.1% 1.34 US$69,713
2025-05-30 2025-06-02 PrS Proposed sale
3.6
Sara Kenkare-Mitra

Officer

Officer
23,020
1.33
US$30,617 		23,020 1.33 US$30,617
2025-05-30 2025-06-02 PrS Proposed sale
3.1
Arnon Rosenthal

Officer; Director

Executive Director
50,242
1.33
US$66,822 		50,242 1.33 US$66,822
2025-05-30 2025-06-02 PrS Proposed sale
3.9
Marc Grasso

Officer

Officer
15,873
1.33
US$21,111 		15,873 1.33 US$21,111
2025-03-05 2025-03-03 S Sale
3.9
GRASSO MARC

Chief Financial Officer

Officer
18,091 -5.5%
1.47
US$26,547 		18,091 -5.5% 1.47 US$26,547
2025-03-05 2025-03-03 S Sale
4.1
Romano Gary

Chief Medical Officer

Officer
16,306 -4.7%
1.47
US$23,927 		16,306 -4.7% 1.47 US$23,927
2025-03-05 2025-03-03 S Sale
3.1
Rosenthal Arnon

Chief Executive Officer

Executive Director
40,330 -1.6%
1.47
US$59,176 		40,330 -1.6% 1.47 US$59,176
2025-03-05 2025-03-03 S Sale
3.6
Kenkare-Mitra Sara

President and Head of R&D

Officer
29,073 -5.1%
1.47
US$42,662 		29,073 -5.1% 1.47 US$42,662
2025-02-28 2025-03-03 PrS Proposed sale
4.1
Gary Romano

Officer

Officer
14,306
1.64
US$23,462 		14,306 1.64 US$23,462
2025-02-28 2025-03-03 PrS Proposed sale
3.1
Arnon Rosenthal

Officer; Director

Executive Director
50,242
1.64
US$82,397 		50,242 1.64 US$82,397
2025-02-28 2025-03-03 PrS Proposed sale
3.9
Marc Grasso

Officer

Officer
15,873
1.64
US$26,032 		15,873 1.64 US$26,032
2025-02-28 2025-03-03 PrS Proposed sale
3.6
Sara Kenkare-Mitra

Officer

Officer
25,516
1.64
US$41,846 		25,516 1.64 US$41,846
2024-12-03 2024-12-02 S Sale
3.9
GRASSO MARC

Chief Financial Officer

Officer
16,489 -4.7%
2.52
US$41,542 		16,489 -4.7% 2.52 US$41,542
2024-12-03 2024-12-02 S Sale
4.1
Romano Gary

Chief Medical Officer

Officer
14,892 -4.1%
2.52
US$37,519 		14,892 -4.1% 2.52 US$37,519
2024-12-03 2024-12-02 S Sale
3.6
Kenkare-Mitra Sara

President and Head of R&D

Officer
26,500 -4.5%
2.52
US$66,764 		26,500 -4.5% 2.52 US$66,764
2024-12-03 2024-12-02 S Sale
3.1
Rosenthal Arnon

Chief Executive Officer

Executive Director
52,172 -2.0%
2.52
US$131,442 		52,172 -2.0% 2.52 US$131,442
2024-11-29 2024-12-02 PrS Proposed sale
4.1
Gary Romano

Officer

Officer
14,306
2.59
US$37,053 		14,306 2.59 US$37,053
2024-11-29 2024-12-02 PrS Proposed sale
3.6
Sara Kenkare-Mitra

Officer

Officer
25,465
2.59
US$65,954 		25,465 2.59 US$65,954
2024-11-29 2024-12-02 PrS Proposed sale
3.9
Marc Grasso

Officer

Officer
15,842
2.59
US$41,031 		15,842 2.59 US$41,031
Explore more

More insider trading research around Alector Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America